{"entity":{"type":"insider","cik":"0001342940","url":"/insider/0001342940","json_url":"/insider/0001342940.json","name":"TVM IV Management GmbH & Co. KG","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":6,"first":"2013-03-28","last":"2014-03-07","span_basis":"filed_date"},"name_variants":[{"name":"TVM IV Management GmbH & Co. KG","source":"filing","n_filings":6,"first_seen":"2013-03-28","last_seen":"2014-03-07"}],"transactions":[{"id":9215330,"accession":"0001012975-14-000141","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001012975-14-000141","line_url":"/filing/0001012975-14-000141","is_derivative":false,"issuer_cik":"0001342938","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001342938","owner_cik":null,"owner_name":"Birner Hubert; Fischer Stefan; Goll Alexandra; SCHUHSLER HELMUT; TVM Capital GmbH; TVM IV GMBH & CO KG; TVM IV Management GmbH & Co. KG; TVM MEDICAL VENTURES GMBH & CO KG; TVM V LIFE SCIENCE VENTURES GMBH & CO KG; TVM V Life Science Ventures Management GmbH & Co. KG","owner_display_name":"Birner Hubert","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":430263.0,"shares_display":"430,263","price_per_share":38.8155,"price_display":"38.82","price_state":"stated","total_value":16700873.4765,"total_display":"16,700,873.48","total_whole":"16,700,873","shares_owned_after":1144932.0,"shares_owned_after_display":"1,144,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-04","filed_date":"2014-03-07","scope":"insider","n_lines":3},{"id":6360714,"accession":"0001012975-14-000138","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001012975-14-000138","line_url":"/filing/0001012975-14-000138","is_derivative":false,"issuer_cik":"0001106929","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001106929","owner_cik":null,"owner_name":"SCHUHSLER HELMUT; TVM MEDICAL VENTURES GMBH & CO KG; Birner Hubert; Fischer Stefan; TVM Capital GmbH; TVM V Life Science Ventures Management GmbH & Co. KG; TVM IV GMBH & CO KG; TVM IV Management GmbH & Co. KG; Goll Alexandra; TVM V LIFE SCIENCE VENTURES GMBH & CO KG","owner_display_name":"SCHUHSLER HELMUT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":430263.0,"shares_display":"430,263","price_per_share":38.8155,"price_display":"38.82","price_state":"stated","total_value":16700873.4765,"total_display":"16,700,873.48","total_whole":"16,700,873","shares_owned_after":1178534.0,"shares_owned_after_display":"1,178,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-04","filed_date":"2014-03-05","scope":"insider","n_lines":3},{"id":9215329,"accession":"0001012975-14-000141","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-14-000141","line_url":"/filing/0001012975-14-000141","is_derivative":false,"issuer_cik":"0001342938","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001342938","owner_cik":null,"owner_name":"Birner Hubert; Fischer Stefan; Goll Alexandra; SCHUHSLER HELMUT; TVM Capital GmbH; TVM IV GMBH & CO KG; TVM IV Management GmbH & Co. KG; TVM MEDICAL VENTURES GMBH & CO KG; TVM V LIFE SCIENCE VENTURES GMBH & CO KG; TVM V Life Science Ventures Management GmbH & Co. KG","owner_display_name":"Birner Hubert","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9071.0,"shares_display":"9,071","price_per_share":38.8337,"price_display":"38.83","price_state":"stated","total_value":352260.4927,"total_display":"352,260.49","total_whole":"352,260","shares_owned_after":459064.0,"shares_owned_after_display":"459,064","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-03","filed_date":"2014-03-07","scope":"insider","n_lines":3},{"id":6360702,"accession":"0001012975-14-000138","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-14-000138","line_url":"/filing/0001012975-14-000138","is_derivative":false,"issuer_cik":"0001106929","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001106929","owner_cik":null,"owner_name":"SCHUHSLER HELMUT; TVM MEDICAL VENTURES GMBH & CO KG; Birner Hubert; Fischer Stefan; TVM Capital GmbH; TVM V Life Science Ventures Management GmbH & Co. KG; TVM IV GMBH & CO KG; TVM IV Management GmbH & Co. KG; Goll Alexandra; TVM V LIFE SCIENCE VENTURES GMBH & CO KG","owner_display_name":"SCHUHSLER HELMUT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9071.0,"shares_display":"9,071","price_per_share":38.8337,"price_display":"38.83","price_state":"stated","total_value":352260.4927,"total_display":"352,260.49","total_whole":"352,260","shares_owned_after":1453414.0,"shares_owned_after_display":"1,453,414","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-03","filed_date":"2014-03-05","scope":"insider","n_lines":3},{"id":6181291,"accession":"0001012975-14-000121","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001012975-14-000121","line_url":"/filing/0001012975-14-000121","is_derivative":false,"issuer_cik":"0001106929","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001106929","owner_cik":null,"owner_name":"TVM IV Management GmbH & Co. KG; TVM Capital GmbH; Birner Hubert; TVM V LIFE SCIENCE VENTURES GMBH & CO KG; TVM MEDICAL VENTURES GMBH & CO KG; TVM IV GMBH & CO KG; Goll Alexandra; SCHUHSLER HELMUT; TVM V Life Science Ventures Management GmbH & Co. KG; Fischer Stefan","owner_display_name":"TVM IV Management GmbH & Co. KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53589.0,"shares_display":"53,589","price_per_share":39.9308,"price_display":"39.93","price_state":"stated","total_value":2139851.6412,"total_display":"2,139,851.64","total_whole":"2,139,852","shares_owned_after":1459209.0,"shares_owned_after_display":"1,459,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-26","filed_date":"2014-02-27","scope":"insider","n_lines":3},{"id":6181282,"accession":"0001012975-14-000121","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-14-000121","line_url":"/filing/0001012975-14-000121","is_derivative":false,"issuer_cik":"0001106929","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001106929","owner_cik":null,"owner_name":"TVM IV Management GmbH & Co. KG; TVM Capital GmbH; Birner Hubert; TVM V LIFE SCIENCE VENTURES GMBH & CO KG; TVM MEDICAL VENTURES GMBH & CO KG; TVM IV GMBH & CO KG; Goll Alexandra; SCHUHSLER HELMUT; TVM V Life Science Ventures Management GmbH & Co. KG; Fischer Stefan","owner_display_name":"TVM IV Management GmbH & Co. KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":176601.0,"shares_display":"176,601","price_per_share":38.9189,"price_display":"38.92","price_state":"stated","total_value":6873116.6589,"total_display":"6,873,116.66","total_whole":"6,873,117","shares_owned_after":1493446.0,"shares_owned_after_display":"1,493,446","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-25","filed_date":"2014-02-27","scope":"insider","n_lines":3},{"id":6330863,"accession":"0001012975-14-000111","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001012975-14-000111","line_url":"/filing/0001012975-14-000111","is_derivative":false,"issuer_cik":"0001106929","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001106929","owner_cik":null,"owner_name":"TVM IV GMBH & CO KG; Birner Hubert; TVM V LIFE SCIENCE VENTURES GMBH & CO KG; Goll Alexandra; TVM IV Management GmbH & Co. KG; TVM V Life Science Ventures Management GmbH & Co. KG; TVM MEDICAL VENTURES GMBH & CO KG; TVM Capital GmbH; Fischer Stefan","owner_display_name":"TVM IV GMBH & CO KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52597.0,"shares_display":"52,597","price_per_share":39.5093,"price_display":"39.51","price_state":"stated","total_value":2078070.6521,"total_display":"2,078,070.65","total_whole":"2,078,071","shares_owned_after":1572670.0,"shares_owned_after_display":"1,572,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-24","filed_date":"2014-02-25","scope":"insider","n_lines":3},{"id":6330855,"accession":"0001012975-14-000111","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-14-000111","line_url":"/filing/0001012975-14-000111","is_derivative":false,"issuer_cik":"0001106929","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001106929","owner_cik":null,"owner_name":"TVM IV GMBH & CO KG; Birner Hubert; TVM V LIFE SCIENCE VENTURES GMBH & CO KG; Goll Alexandra; TVM IV Management GmbH & Co. KG; TVM V Life Science Ventures Management GmbH & Co. KG; TVM MEDICAL VENTURES GMBH & CO KG; TVM Capital GmbH; Fischer Stefan","owner_display_name":"TVM IV GMBH & CO KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7880.0,"shares_display":"7,880","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":315200.0,"total_display":"315,200.00","total_whole":"315,200","shares_owned_after":1606272.0,"shares_owned_after_display":"1,606,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-21","filed_date":"2014-02-25","scope":"insider","n_lines":3},{"id":6816373,"accession":"0001012975-14-000103","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-14-000103","line_url":"/filing/0001012975-14-000103","is_derivative":false,"issuer_cik":"0001106929","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001106929","owner_cik":null,"owner_name":"TVM V LIFE SCIENCE VENTURES GMBH & CO KG; TVM Capital GmbH; TVM IV Management GmbH & Co. KG; TVM IV GMBH & CO KG; TVM V Life Science Ventures Management GmbH & Co. KG; Fischer Stefan; Birner Hubert; Goll Alexandra; TVM MEDICAL VENTURES GMBH & CO KG","owner_display_name":"TVM V LIFE SCIENCE VENTURES GMBH & CO KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":40.1853,"price_display":"40.19","price_state":"stated","total_value":401853.0,"total_display":"401,853.00","total_whole":"401,853","shares_owned_after":1611306.0,"shares_owned_after_display":"1,611,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-20","scope":"insider","n_lines":3},{"id":5469804,"accession":"0001012975-13-000125","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001012975-13-000125","line_url":"/filing/0001012975-13-000125#line-7","is_derivative":false,"issuer_cik":"0001106929","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001106929","owner_cik":null,"owner_name":"TVM IV GMBH & CO KG; TVM Capital GmbH; TVM IV Management GmbH & Co. KG; TVM V Life Science Ventures Management GmbH & Co. KG; TVM V LIFE SCIENCE VENTURES GMBH & CO KG; Birner Hubert; TVM MEDICAL VENTURES GMBH & CO KG; Goll Alexandra; Fischer Stefan","owner_display_name":"TVM IV GMBH & CO KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":132949.0,"shares_display":"132,949","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":1861286.0,"total_display":"1,861,286.00","total_whole":"1,861,286","shares_owned_after":1617694.0,"shares_owned_after_display":"1,617,694","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-26","filed_date":"2013-03-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001177648","name":"ENANTA PHARMACEUTICALS INC","url":"/issuer/0001177648","role":"Ten percent owner","n_filings":6,"first_seen":"2013-03-28","last_seen":"2014-03-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001342940","retrieved_at":"2026-08-22T21:47:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}